Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2020 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
LTRN on Nasdaq
Shares outstanding
10,781,082
Price per share
$3.03
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,284,349
Total reported value
$9,928,721
% of total 13F portfolios
0%
Share change
+33,179
Value change
+$166,361
Number of holders
31
Price from insider filings
$3.03
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Bios Equity Partners, LP 10% $4,153,175 1,075,952 CAVU MANAGEMENT, LP 12 Jun 2025

As of 30 Sep 2025, 31 institutional investors reported holding 2,284,349 shares of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN). This represents 21% of the company’s total 10,781,082 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) together control 21% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BIOS Capital Management, LP 9.4% 1,015,715 -5.6% 5% $4,418,360
VANGUARD GROUP INC 3.6% 384,041 +5.6% 0% $1,670,578
CM Management, LLC 2.1% 225,000 +12% 0.82% $978,750
RENAISSANCE TECHNOLOGIES LLC 0.93% 100,100 +10% 0% $435,435
GEODE CAPITAL MANAGEMENT, LLC 0.85% 92,081 +0.21% 0% $400,647
Voss Capital, LP 0.46% 50,000 0% 0.01% $217,500
NewEdge Advisors, LLC 0.44% 47,279 -16% 0% $205,674
BlackRock, Inc. 0.4% 43,090 +1.9% 0% $187,443
DIMENSIONAL FUND ADVISORS LP 0.37% 40,144 -1.9% 0% $174,626
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.36% 39,094 0% $170,059
Westside Investment Management, Inc. 0.33% 35,900 0% 0.02% $156,168
UBS Group AG 0.31% 33,156 +34% 0% $144,228
HORIZON KINETICS ASSET MANAGEMENT LLC 0.27% 28,791 +4.4% 0% $125,241
Bank of New York Mellon Corp 0.25% 26,481 -0% 0% $115,193
DAVENPORT & Co LLC 0.24% 25,814 0% 0% $112,291
STATE STREET CORP 0.22% 23,652 0% 0% $102,886
COMMONWEALTH EQUITY SERVICES, LLC 0.17% 18,161 0% 0% $79,000
TWO SIGMA INVESTMENTS, LP 0.15% 16,041 0% $69,778
NORTHERN TRUST CORP 0.14% 15,589 0% 0% $67,812
Sanctuary Advisors, LLC 0.09% 10,000 0% 0% $35,400
GROUP ONE TRADING LLC 0.05% 5,072 +71% 0% $22,063
SBI Securities Co., Ltd. 0.02% 2,143 -0.51% 0% $9,322
Allworth Financial LP 0.02% 2,100 +2000% 0% $9,135
WELLS FARGO & COMPANY/MN 0.02% 1,725 -65% 0% $7,504
SIMPLEX TRADING, LLC 0.01% 1,426 0% $6,000

Institutional Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 23,814 $72,156 -$6,060 $3.03 1
2025 Q3 2,284,349 $9,928,721 +$166,361 $4.35 31
2025 Q2 2,241,170 $7,081,768 -$615,229 $3.16 34
2025 Q1 2,423,714 $8,580,099 -$194,908 $3.54 30
2024 Q4 2,499,825 $7,996,845 -$160,960 $3.19 32
2024 Q3 1,335,871 $4,902,351 +$118,888 $3.67 31
2024 Q2 1,286,016 $6,005,302 +$572,129 $4.67 39
2024 Q1 1,108,429 $9,753,422 +$324,907 $8.80 33
2023 Q4 1,155,318 $4,944,504 +$6,767 $4.28 29
2023 Q3 1,153,745 $3,934,035 -$18,036 $3.41 26
2023 Q2 1,152,036 $6,497,253 +$385,814 $5.64 25
2023 Q1 1,083,678 $5,233,851 +$124,192 $4.83 21
2022 Q4 893,594 $5,395,811 -$1,734,422 $6.04 21
2022 Q3 1,436,757 $6,840,000 +$106,232 $4.78 23
2022 Q2 1,417,902 $8,060,000 -$230,429 $5.70 25
2022 Q1 1,452,881 $10,384,000 -$1,687,241 $7.14 25
2021 Q4 1,658,393 $13,121,000 -$563,118 $7.98 31
2021 Q3 1,400,629 $15,656,000 +$604,001 $11.18 24
2021 Q2 1,346,716 $19,660,000 -$1,578,997 $14.60 19
2021 Q1 1,403,470 $25,458,000 +$23,880,194 $18.14 21
2020 Q4 82,988 $1,597,009 -$1,643,167 $19.24 10
2020 Q3 160,127 $3,017,000 +$710,980 $18.84 11
2020 Q2 122,153 $1,551,000 +$1,551,000 $12.39 5